# Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor

> **NCT03191123** · NA · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 100 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular
- Survival Rate

## Interventions

- **PROCEDURE:** hepatic resection
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT03191123
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07-05
- **Primary completion:** 2018-07-05
- **Final completion:** 2019-07-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03191123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03191123, "Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03191123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*